Human subjects research with prisoners: putting the ethical question in context
By Osagie K. Obasogie and Keramet A. Reiter,
Bioethics
| 12. 16. 2010
[Commentary]
We write in response to the conversation initiated in Volume 24.1 of Bioethics, which focused on the role of prisoners in biomedical and behavioral research. As interdisciplinary legal scholars who have researched the history, ethics, and current practices of prison research in the United States, we write to encourage further dialogue about the Institute of Medicine's (IOM) recommendations to reform current standards for prisoners' participation as human subjects. Specifically, we challenge three critical assumptions, which underlie several articles in the Bioethics special issue.
First, we challenge the idea that a risk-benefit assessment applied to prisoner participants in research is too restrictive.1 On the contrary, we argue that it is too permissive. The IOM's risk-benefit proposal – the most significant of its five main recommendations – is designed to relax current standards that categorically restrict prisoners' participation as human subjects to four narrow situations that directly benefit prisoners.2 Current policies were implemented in response to substantial abuses directly connected to prisoners' vulnerability and deplorable prison conditions; a 1976 Commission concluded that widespread research in prisons should not be...
Related Articles
By Jeffrey Gettleman and Maya Tekeli, The New York Times | 09.24.2025
For some Greenlanders, sorry isn’t enough.
The prime minister of Denmark, Mette Frederiksen, made a special visit Wednesday to Greenland’s capital, Nuuk, to apologize in person for a traumatic chapter in Greenlandic history, when Danish doctors forced birth control on...
By Emma McDonald Kennedy
| 09.25.2025
In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.
The response to the...
By Marianne Lamers, NEMO Kennislink [cites CGS' Katie Hasson] | 09.23.2025
Een rijtje gespreide vulva’s gaapt de bezoeker aan. Zó ziet een bevalling eruit, en zó een baarmoeder met foetus. Een zwangerschap, maar dan zonder zwangere vrouw, gestript van zorgen, gêne en pijn. De zwangerschapsmodellen en oefenbekkens, te zien in de...
By Johana Bhuiyan, The Guardian | 09.23.2025
In March 2021, a 25-year-old US citizen was traveling through Chicago’s Midway airport when they were stopped by US border patrol agents. Though charged with no crime, the 25-year-old was subjected to a cheek swab to collect their DNA, which...